The Centre for Commercialization of Regenerative Medicine (CCRM): CCRM Announces Its Inaugural Board of Directors
Powerhouse of Regenerative Medicine Expertise on Board Reflects Interest in CCRM's Vision.

(firmenpresse) - TORONTO, ONTARIO -- (Marketwire) -- 09/28/11 -- (CCRM) is proud to announce its inaugural . The Board represents extensive experience in company creation, international academic excellence and seasoned leaders sourced from the regenerative medicine industry. Chaired by Greg Bonfiglio, Managing Partner of Proteus Venture Partners, the Board is poised to establish CCRM as an international leader in regenerative medicine commercialization.
Michael May, CEO of CCRM, is delighted with the caliber of the Board, "We are proud to be working with this accomplished group of regenerative medicine leaders". May adds, "It is a reflection of the level of interest in the capital-efficient commercialization model offered by CCRM."
CCRM, a Canadian not-for-profitorganization, supports the development of technologies that accelerate the commercialization of stem cell- and biomaterials-based technologies and therapies.A network of academics, industry and entrepreneurs, CCRM translates scientific discoveries into marketable products for patients. CCRM launched in Toronto's Discovery District on June 14, 2011.
Contacts:
The Centre for Commercialization of Regenerative Medicine
Sandra Donaldson
Manager, Communications
416.978.0553 or Cell: 647.926.1228
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: MARKET WIRE
Datum: 28.09.2011 - 13:55 Uhr
Sprache: Deutsch
News-ID 70595
Anzahl Zeichen: 0
contact information:
Town:
TORONTO, ONTARIO
Kategorie:
Health & Nutrition
Diese Pressemitteilung wurde bisher 256 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"The Centre for Commercialization of Regenerative Medicine (CCRM): CCRM Announces Its Inaugural Board of Directors"
steht unter der journalistisch-redaktionellen Verantwortung von
CCRM (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).